Genentech, *the* original biotech company, is celebrating its 50th anniversary in 2026. VP, US External Affairs Joy Russell stopped by the STAT Brand Studio multimedia lounge at #statsummit to talk with Britt Whitmore about the company's past, present, future, and its patient impact.

As global biotech competition intensifies and new R&D centers emerge, Boston faces a pivotal moment. Can it continue to lead the world in life sciences?

Join us for an in-person event in Cambridge, MA next month to find out!

www.statnews.com/event/local-...

At #STATBreakthrough Summit West, SBS spoke with Boston Scientific’s CMO about 3 AI use cases in cardiology — from scaling ECG data to spotting heart failure early.

We also discussed the intersection of evidence-based medicine and AI:

www.statnews.com/sponsor/2025...

@statnews.com #cardiology

SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases

www.statnews.com/event/rare-a...

SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases

www.statnews.com/event/rare-a...

Over the past two years, City of Hope has significantly expanded, transforming cancer care and improving patient access. At the STAT Summit, Marcel van den Brink, M.D., Ph.D., highlighted their clinical trial network, novel therapies, and research on the microbiome's role in immune response.

“I think this personalized pathway is what we’re really driving towards…”

Hear more from Dr. Joan Cangiarella, Elaine Langone Professor of Pathology at the NYU Grossman School of Medicine and Senior Associate Dean for Education, Faculty, and Academic Affairs at @nyulangone.